Physician profile
Jack Dwosh
NPI 1033180724
$176.30
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $45.72 · 2021: $19.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $57.94 | 2019-2020 | |
| Antares Pharma, INC. | $28.82 | 2019-2020 | |
| Axonics, INC. | $19.79 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2020 | |
| Janssen Biotech, INC. | $14.92 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.57 | 2019 | |
| Medtronic USA, INC. | $12.41 | 2019 | |
| Zyla Life Sciences, INC. | $11.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Dwosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.